Farzadegan H - Search Results

1

Vitamin A supplementation and human immunodeficiency virus load in injection drug users.

Semba RD, Lyles CM, Margolick JB, Caiaffa WT, Farzadegan H, Cohn S, Vlahov D. Semba RD, et al. Among authors: farzadegan h. J Infect Dis. 1998 Mar;177(3):611-6. doi: 10.1086/514235. J Infect Dis. 1998. PMID: 9498439 Clinical Trial.

2

Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users.

Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D. Markham RB, et al. Among authors: farzadegan h. J Infect Dis. 1995 Apr;171(4):797-804. doi: 10.1093/infdis/171.4.797. J Infect Dis. 1995. PMID: 7706805

3

Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression.

Künzi MS, Farzadegan H, Margolick JB, Vlahov D, Pitha PM. Künzi MS, et al. Among authors: farzadegan h. J Infect Dis. 1995 Apr;171(4):822-8. doi: 10.1093/infdis/171.4.822. J Infect Dis. 1995. PMID: 7706808

4

Association between anti-CD4 antibodies and a decline in CD4+ lymphocytes in human immunodeficiency virus type 1 seroconverters.

Keay S, Wecksler W, Wasserman SS, Margolick J, Farzadegan H. Keay S, et al. Among authors: farzadegan h. J Infect Dis. 1995 Feb;171(2):312-9. doi: 10.1093/infdis/171.2.312. J Infect Dis. 1995. PMID: 7844366

5

Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users.

Farzadegan H, Vlahov D, Solomon L, Muñoz A, Astemborski J, Taylor E, Burnley A, Nelson KE. Farzadegan H, et al. J Infect Dis. 1993 Aug;168(2):327-31. doi: 10.1093/infdis/168.2.327. J Infect Dis. 1993. PMID: 8335969

6

Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T lymphocyte subsets, and stage of infection in homosexual men.

Margolick JB, Farzadegan H, Hoover DR, Saah AJ. Margolick JB, et al. Among authors: farzadegan h. J Infect Dis. 1996 Feb;173(2):468-71. doi: 10.1093/infdis/173.2.468. J Infect Dis. 1996. PMID: 8568314

7

The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users.

Manoff SB, Farzadegan H, Muñoz A, Astemborski JA, Vlahov D, Rizzo RT, Solomon L, Graham NM. Manoff SB, et al. Among authors: farzadegan h. J Infect Dis. 1996 Aug;174(2):299-308. doi: 10.1093/infdis/174.2.299. J Infect Dis. 1996. PMID: 8699059

8

The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study.

Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ. Glesby MJ, et al. Among authors: farzadegan h. J Infect Dis. 1996 Dec;174(6):1332-6. doi: 10.1093/infdis/174.6.1332. J Infect Dis. 1996. PMID: 8940228 Clinical Trial.

9

Vitamin A levels and human immunodeficiency virus load in injection drug users.

Semba RD, Farzadegan H, Vlahov D. Semba RD, et al. Among authors: farzadegan h. Clin Diagn Lab Immunol. 1997 Jan;4(1):93-5. doi: 10.1128/cdli.4.1.93-95.1997. Clin Diagn Lab Immunol. 1997. PMID: 9008289 Free PMC article.

10

Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count.

Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H. Vlahov D, et al. Among authors: farzadegan h. JAMA. 1998 Jan 7;279(1):35-40. doi: 10.1001/jama.279.1.35. JAMA. 1998. PMID: 9424041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters